Does DUPILUMAB Cause Product prescribing issue? 1,715 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,715 reports of Product prescribing issue have been filed in association with DUPILUMAB (Dupixent). This represents 0.5% of all adverse event reports for DUPILUMAB.
1,715
Reports of Product prescribing issue with DUPILUMAB
0.5%
of all DUPILUMAB reports
5
Deaths
39
Hospitalizations
How Dangerous Is Product prescribing issue From DUPILUMAB?
Of the 1,715 reports, 5 (0.3%) resulted in death, 39 (2.3%) required hospitalization.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 1,715 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Product prescribing issue?
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
MORPHINE (288)
Which DUPILUMAB Alternatives Have Lower Product prescribing issue Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE